Pursuant to the Company's Code of Conduct for Prohibition of Insider Trading formulated and adopted under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 duly amended, Unichem Laboratories has informed that the Trading Window for dealing in shares of the Company will be closed from January 1, 2026 for Designated Persons, Directors, Insiders, and their Immediate Relatives and shall open 48 hours after the financial results for the quarter and nine months ended December 31, 2025, are made public.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1696.65 |
| Dr. Reddys Lab | 1218.30 |
| Cipla | 1226.65 |
| Zydus Lifesciences | 936.00 |
| Lupin | 2339.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: